579 results
Page 11 of 29
6-K
EX-99.1
5io0gcyd5rvesutuofj
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
ixszy
27 Nov 13
Teva Announces Additional Regulatory Exclusivity for Treanda® (Bendamustine Hci) for Injection
12:00am
6-K
EX-99.1
d915mifm1 nl8cn4q1
25 Nov 13
Teva and Mylan Settle Copaxone® Patent Litigation In France, the Uk and the Netherlands
12:00am
6-K
EX-99.1
ihvwrxb
25 Nov 13
Live Filing
12:00am
6-K
EX-99.1
syq8mv3
19 Nov 13
Live Filing
12:00am
6-K
EX-99.1
s2rnrc3
18 Nov 13
Teva Announces Updates to Oncology Biologic Portfolio
12:00am
6-K
EX-99.1
6snvorh p0jj
31 Oct 13
Teva Reports Third Quarter 2013 Results
12:00am
6-K
l3l2bfu0xisorny0
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
lcokk6f
30 Oct 13
Teva Announces Departure of President and Ceo
12:00am
6-K
EX-99.1
c4sd0zo0tygbw kg7o77
10 Oct 13
Live Filing
12:00am
6-K
EX-99.1
ic6n3wzw
10 Oct 13
Live Filing
12:00am
6-K
EX-99.1
l8xdwgnwa0
9 Oct 13
Teva R&D in Focus - Respiratory Webinar for the investment communityOctober 8th, 2013
12:00am
6-K
EX-99.1
48ov5cdbdfd cit6
4 Oct 13
Live Filing
12:00am
6-K
EX-99.1
udviiaww3rq2t9c
3 Oct 13
Teva Announces Favorable Ruling on Copaxone Patent Litigation In the Netherlands
12:00am
6-K
EX-99.1
5ua6v7
3 Oct 13
Teva to Present Further Results of Twenty-year Open-label Extension Study of Glatiramer Acetate 20 MG Daily for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
g2wf17 8sfnt
1 Oct 13
Live Filing
12:00am
6-K
EX-99.1
ds274osx9nnzzr
1 Oct 13
Teva Announces Launch of Generic Zemplar® In the United States
12:00am
6-K
EX-99.1
csinwgg8fofz
30 Sep 13
Live Filing
12:00am
6-K
EX-99.1
1m8p1q
26 Sep 13
Live Filing
12:00am
6-K
EX-99.1
31zdsosx sn
24 Sep 13
Teva Announces Exclusive Launch of Generic Adenoscan® In the United States
12:00am